• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤标志物在妇科肿瘤学中的作用。

The role of tumor markers in gynecologic oncology.

作者信息

Olt G, Berchuck A, Bast R C

机构信息

Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina 27710.

出版信息

Obstet Gynecol Surv. 1990 Sep;45(9):570-7. doi: 10.1097/00006254-199009000-00002.

DOI:10.1097/00006254-199009000-00002
PMID:1697940
Abstract

Human chorionic gonadotropin is a highly sensitive and specific tumor marker for gestational trophoblastic neoplasia that accurately reflects tumor volume and the clinical course of disease. In women with endodermal sinus tumors and embryonal carcinomas, alpha-fetoprotein usually is a reliable marker, and it accurately predicts the presence of yolk sac elements in mixed germ cell tumors. CA 125 is the most widely utilized tumor marker presently available for use in patients with epithelial ovarian cancer. It has utility in monitoring therapy and differentiating benign from malignant pelvic masses. Measurement of serial CA 125 levels in postmenopausal women may facilitate screening for occult early stage disease. In the future, monoclonal antibodies that recognize tumor-associated antigens may prove useful for radionuclide imaging.

摘要

人绒毛膜促性腺激素是妊娠滋养细胞肿瘤高度敏感且特异的肿瘤标志物,能准确反映肿瘤体积及疾病的临床进程。对于患有内胚窦瘤和胚胎癌的女性,甲胎蛋白通常是可靠的标志物,且能准确预测混合性生殖细胞肿瘤中卵黄囊成分的存在。CA 125是目前用于上皮性卵巢癌患者的应用最为广泛的肿瘤标志物。它在监测治疗以及鉴别盆腔肿块的良恶性方面具有作用。对绝经后女性连续测定CA 125水平可能有助于筛查隐匿性早期疾病。未来,识别肿瘤相关抗原的单克隆抗体可能被证明对放射性核素成像有用。

相似文献

1
The role of tumor markers in gynecologic oncology.肿瘤标志物在妇科肿瘤学中的作用。
Obstet Gynecol Surv. 1990 Sep;45(9):570-7. doi: 10.1097/00006254-199009000-00002.
2
Tumour markers in gynaecologic oncology.
Scand J Clin Lab Invest Suppl. 1991;206:60-70.
3
Pros and cons of gynecologic tumor markers.
Cancer. 1987 Oct 15;60(8 Suppl):1984-92. doi: 10.1002/1097-0142(19901015)60:8+<1984::aid-cncr2820601510>3.0.co;2-w.
4
Gynecologic tumor markers.
Semin Surg Oncol. 1990;6(6):305-13. doi: 10.1002/ssu.2980060604.
5
Serum tumor markers.血清肿瘤标志物
Am Fam Physician. 2003 Sep 15;68(6):1075-82.
6
Multiple biochemical markers in patients with gynecologic malignancies.妇科恶性肿瘤患者的多种生化标志物
Cancer. 1980 Mar 1;45(5):948-53. doi: 10.1002/1097-0142(19800301)45:5<948::aid-cncr2820450519>3.0.co;2-q.
7
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.基于LOCI™技术的肿瘤标志物检测法对妇科癌症中肿瘤标志物CA 15-3、CA 125、癌胚抗原(CEA)、CA 19-9和甲胎蛋白(AFP)的临床检测性能
Tumour Biol. 2017 Oct;39(10):1010428317730246. doi: 10.1177/1010428317730246.
8
The use of serum tumor markers in the management of patients with malignancy.血清肿瘤标志物在恶性肿瘤患者管理中的应用。
J Cancer Res Clin Oncol. 1993;119(11):635-6. doi: 10.1007/BF01215980.
9
Biochemical markers in the plasma and tumors of patients with gynecologic malignancies.妇科恶性肿瘤患者血浆和肿瘤中的生化标志物。
Cancer. 1981 Jul 15;48(2 Suppl):495-503. doi: 10.1002/1097-0142(19810715)48:1+<495::aid-cncr2820481310>3.0.co;2-f.
10
Tumour markers in the detection of gynaecological cancer.肿瘤标志物在妇科癌症检测中的应用
Br J Hosp Med. 1981 Oct;26(4):381-2, 385-6.

引用本文的文献

1
Expression of HER2 in high-grade urothelial carcinoma based on Chinese expert consensus and the clinical effects of disitamab vedotin-tislelizumab combination therapy in the treatment of advanced patients.基于中国专家共识的HER2在高级别尿路上皮癌中的表达及双特异性抗体迪西他单抗-替雷利珠单抗联合治疗晚期患者的临床疗效
Front Pharmacol. 2024 Feb 22;15:1355081. doi: 10.3389/fphar.2024.1355081. eCollection 2024.
2
CA-125 concentrations in the serum and pregnancy outcome in IVF cycles.体外受精周期中血清CA - 125浓度与妊娠结局
J Assist Reprod Genet. 1998 Jul;15(6):390-4. doi: 10.1023/a:1022589101648.
3
Ascites with a raised CA 125.
伴有CA 125升高的腹水。
J R Soc Med. 1997 Aug;90(8):448-9. doi: 10.1177/014107689709000810.